300158 Stock Overview
Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 300158 from our risk checks.
Shanxi Zhendong Pharmaceutical Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥3.94 |
52 Week High | CN¥8.47 |
52 Week Low | CN¥3.62 |
Beta | 0.36 |
11 Month Change | 3.96% |
3 Month Change | -12.25% |
1 Year Change | -25.94% |
33 Year Change | -43.55% |
5 Year Change | -33.22% |
Change since IPO | -59.62% |
Recent News & Updates
Shareholder Returns
300158 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -8.4% | -4.0% | -2.3% |
1Y | -25.9% | -10.0% | -17.3% |
Return vs Industry: 300158 underperformed the CN Pharmaceuticals industry which returned -10% over the past year.
Return vs Market: 300158 underperformed the CN Market which returned -17.3% over the past year.
Price Volatility
300158 volatility | |
---|---|
300158 Average Weekly Movement | 6.2% |
Pharmaceuticals Industry Average Movement | 5.3% |
Market Average Movement | 5.5% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 300158's share price has been volatile over the past 3 months.
Volatility Over Time: 300158's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 3,576 | Lianmin Yang | www.zdjt.com |
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally. It offers drugs for various fields, including cancer, cardiovascular, infectious disease, antibiotics, cardiocerebrovascular, antitumor, gastrointestinal, and respiratory, as well as urinary, tonic, dermatology, blood hematopoietic, digestion, urology, and heart and brain; vitamins; Chinese medicines in the form of pills, tablets, capsules, powders, and granules, as well as herbal medicines; and food and beverages for various health applications. The company engages in the pharmaceutical wholesale and logistics distribution business; tending, planting, processing, storage, and decoction of seedlings for medication applications; and offers home care and personal care products.
Shanxi Zhendong Pharmaceutical Co.,Ltd Fundamentals Summary
300158 fundamental statistics | |
---|---|
Market cap | CN¥3.96b |
Earnings (TTM) | -CN¥20.49m |
Revenue (TTM) | CN¥3.46b |
1.1x
P/S Ratio-193.3x
P/E RatioIs 300158 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300158 income statement (TTM) | |
---|---|
Revenue | CN¥3.46b |
Cost of Revenue | CN¥1.76b |
Gross Profit | CN¥1.70b |
Other Expenses | CN¥1.72b |
Earnings | -CN¥20.49m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 27, 2024
Earnings per share (EPS) | -0.02 |
Gross Margin | 49.13% |
Net Profit Margin | -0.59% |
Debt/Equity Ratio | 0.002% |
How did 300158 perform over the long term?
See historical performance and comparison